SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 2
|
records per page:
next > | last >>
|
|
pages:
1
2
|
presentations:
1 to
50 of
60
|
WELCOME AND DAILY ROADMAP
James Hoxie
University of Pennsylvania, Berwyn, PA, USA
HIV NONHUMAN PRIMATE MODELS FOR STUDIES OF VIRUS PATHOGENESIS, PERSISTENCE, AND CURE
(ABSTRACT
16)
Michaela Müller-Trutwin
Institut Pasteur, Paris, France
CHILDREN EXPOSED TO HIV, BUT UNINFECTED: EVIDENCE FOR ACTION
(ABSTRACT
17)
Andrew J Prendergast
Queen Mary University of London, London, United Kingdom
WELCOME AND DAILY ROADMAP
Landon Myer
University of Cape Town, Cape Town, South Africa
NEW INSIGHTS INTO HIV RNA BIOLOGY
(ABSTRACT
60)
Michael Summers
University of Maryland Baltimore County, Baltimore, MD, USA
UNDERSTANDING THE EPIDEMIOLOGY OF COVID-19: A GLOBAL PERSPECTIVE
(ABSTRACT
61)
Muge Cevik
University of St Andrews, St Andrews, United Kingdom
WELCOME AND DAILY ROADMAP
Elaine J Abrams
Columbia University, New York, NY, USA
NEW ANTIRETROVIRALS AND THE FUTURE OF HIV TREATMENT AND PREVENTION
(ABSTRACT
116)
Chloe L Orkin
Queen Mary University of London, London, United Kingdom
PAST AND FUTURE OF HIV VACCINES
(ABSTRACT
117)
Mark Feinberg
IAVI, New York, NY, USA
WELCOME AND DAILY ROADMAP
Sharon L. Hillier
University of Pittsburgh Medical Center, Pittsburgh, PA, USA
IMAGING VIRAL LIFE CYCLES
(ABSTRACT
14)
Hans-Georg Kräusslich
Heidelberg University, Heidelberg, Germany
Wesley I Sundquist
University of Utah School of Medicine, Salt Lake City, UT, USA
DISPARITIES IN HEALTH: FROM HIV TO COVID-19 AND BEYOND
(ABSTRACT
15)
James E.K. Hildreth
Meharry Medical College, Nashville, TN, USA
Carlos del Rio
Emory University, Atlanta, GA, USA
WELCOME AND DAILY ROADMAP
Elaine J Abrams
Columbia University, New York, NY, USA
HIV-1 BNABS: LOOKING AHEAD
(ABSTRACT
36)
Marina Caskey
The Rockefeller University, New York, NY, USA
Peter W Hunt
University of California San Francisco, San Francisco, CA, USA
SUSTAINED DELIVERY AND LONG-ACTING AGENTS FOR PREVENTION OF HIV
(ABSTRACT
37)
Linda-Gail Bekker
Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
Sharon L. Hillier
University of Pittsburgh Medical Center, Pittsburgh, PA, USA
WELCOME AND DAILY ROADMAP
Richard A Koup
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
ELITE CONTROLLERS: A MODEL FOR A FUNCTIONAL CURE OF HIV-1 INFECTION
(ABSTRACT
57)
Xu Yu
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Nicolas Chomont
Université de Montréal, Montreal, Canada
HIV TREATMENT IN PREGNANCY: BEYOND PREVENTION OF VERTICAL TRANSMISSION
(ABSTRACT
58)
Shahin Lockman
Brigham and Women's Hospital, Boston, MA, USA
Elaine J Abrams
Columbia University, New York, NY, USA
HIV CURE FROM BENCH TO BEDSIDE
(ABSTRACT
17)
Sharon R. Lewin
University of Melbourne, Melbourne, Victoria, Australia
UNIVERSAL TEST AND TREAT (UTT): LESSONS FROM THE PAST AND FOR THE FUTURE
(ABSTRACT
18)
Kevin M. De Cock
Centers for Disease Control and Prevention, Nairobi, Kenya
PREVENTING HIV AMONG PEOPLE WHO INJECT DRUGS: PLUS ÇA CHANGE, PLUS ÇA MÊME CHOSE
(ABSTRACT
62)
Steffanie A Strathdee
University of California San Diego, La Jolla, CA, USA
SEX DIFFERENCES IN HIV
(ABSTRACT
63)
Eileen P Scully
Johns Hopkins University, Baltimore, MD, USA
RECENT ADVANCES IN THE DIAGNOSIS, TREATMENT, AND PREVENTION OF TUBERCULOSIS
(ABSTRACT
111)
Gavin Churchyard
Aurum Institute, Johannesburg, Gauteng, South Africa
ENGINEERING VACCINE IMMUNITY
(ABSTRACT
112)
Shane Crotty
La Jolla Institute for Immunology, La Jolla, CA, USA
DENIAL, DOOM, OR DESTINY? RESURGENT STIS IN HIV CARE AND PREVENTION
(ABSTRACT
12)
Jeanne M Marrazzo
University of Alabama, Birmingham, USA
INFLAMMATION: TAMING THE FLAMES
(ABSTRACT
13)
Irini Sereti
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
RAISING THE WALL IN MATERNAL/FETAL IMMUNITY
(ABSTRACT
67)
Sallie Permar
Duke Human Vaccine Institute, Durham, NC, USA
HUGGING PHYLOGENETIC TREES: USE OF MOLECULAR ANALYSIS FOR PUBLIC HEALTH INTERVENTION
(ABSTRACT
68)
Alexandra M. Oster
CDC, Atlanta, GA, USA
THE CHALLENGES OF HIV TREATMENT IN AN ERA OF POLYPHARMACY
(ABSTRACT
120)
David Back
University of Liverpool, Liverpool, United Kingdom
NEUROHIV: WHAT THE VIRUS TELLS US
(ABSTRACT
121)
Ronald Swanstrom
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
THE EARLY DAYS OF AIDS: LOOKING BACK AND THINKING AHEAD
(ABSTRACT
12)
Harold W. Jaffe
Centers for Disease Control and Prevention, Atlanta, GA, USA
PATHOGENESIS OF TUBERCULOSIS AND VACCINE PREVENTION
(ABSTRACT
13)
JoAnne L Flynn
University of Pittsburgh, Pittsburgh, PA, USA
THE VAGINAL MICROBIOME AND ACQUISITION OF HIV INFECTION
(ABSTRACT
64)
Nichole Klatt
University of Washington, Seattle, WA, USA
ADDRESSING MENTAL HEALTH: A CRUCIAL COMPONENT TO ENDING THE HIV EPIDEMIC
(ABSTRACT
65)
Robert H. Remien
HIV Center for Clinical & Behavioral Studies, NYS Psychiatric Institute and Columbia University, New York, NY, USA
GROWING UP WITH HIV
(ABSTRACT
109)
Patricia M. Flynn
St. Jude Children's Research Hospital, Memphis, TN, USA
ARE WE ON THE FAST TRACK TO 'BEND AND END' THE HIV EPIDEMICS?
(ABSTRACT
110)
Helen Anne Weiss
London School of Hygiene & Tropical Medicine, London, United Kingdom
THE EMERGING POTENTIAL FOR HIV CURE FOR INFANTS, CHILDREN, AND ADULTS
Jintanat Ananworanich
US Military HIV Research Program, Thai Red Cross, Bethesda, MD, USA
ADVANCES IN CELLULAR THERAPY IN CANCER AND HIV
Carl H June
University of Pennsylvania, Philadelphia, PA, USA
(PREVENTING) THE COMING EPIDEMIC: HIV IN YOUTH
Shannon L Hader
US Centers for Disease Control and Prevention, Atlanta, GA, USA
ANTIVIRAL VACCINE DEVELOPMENT FROM A (AIDS) TO Z (ZIKA)
Barney S. Graham
NIAID, National Institutes of Health, Bethesda, MD, USA
IF YOU CAN MAKE IT THERE: ENDING THE HIV EPIDEMIC IN NEW YORK
Demetre C Daskalakis
NYC Department of Health and Mental Hygiene, New York, NY, USA
HTLV-1: THE OTHER HUMAN RETROVIRUS
Charles RM Bangham
Imperial College London, London, United Kingdom
Harnessing Antibodies for HIV-1 Prevention and Treatment
John R. Mascola
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
Antiretroviral Therapy: Where Are We Now? Where Are We Going?
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Progress in Gene Therapy for HIV Cure
Paula M. Cannon
University of Southern California, Los Angeles, CA, United States
HIV in Transgender Populations: Charted and Uncharted Waters
Tonia C. Poteat
Johns Hopkins University, Baltimore, MD, United States
Tuberculosis: Why Do I Have to Take So Many Pills?
Eric J. Rubin
Harvard School of Public Health, Boston, MA, United States
The Evolving Epidemiology of HIV Infection in Persons Who Inject Drugs: Indiana 2015
John T. Brooks
Centers for Disease Control and Prevention, Atlanta, GA, United States
PrEP for HIV Prevention: What We Know and What We Still Need to Know for Implementation
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, United States
Specific HIV Integration Sites Linked to Clonal Expansion and Persistence of Cells
Stephen H. Hughes
National Cancer Institute, Frederick, MD, United States
|
<< first | < prev
page:
of 2
|
records per page:
next > | last >>
|
|
pages:
1
2
|
presentations:
1 to
50 of
60
|
